Tom Kosnik

🌱 Welcome to ASAGI Labs Ventures ASAGI Labs Ventures (ALV) is a Japan-based independent venture capital firm focused on Longevity and the science of aging. Advances in aging research, AI, and multimodal data are transforming how we understand, predict, and intervene in aging. We believe this shift will redefine healthcare or our society—from treatment to prevention, from disease-centric to human-centric systems. ASAGI Labs Ventures partners with startups, researchers, and industry leaders who are building: - Aging clocks and biomarkers - Preventive and predictive healthcare solutions - AI-driven diagnostics and interventions - New business models beyond traditional healthcare frameworks Rooted in Japan’s super-aged society and connected to global innovation ecosystems, we aim to bridge science, capital, and real-world implementation. We look forward to sharing insights, investments, and collaborations from the frontier of longevity. — ASAGI Labs Ventures #Longevity #AgingScience #VentureCapital #HealthcareInnovation #Japan Motoshi Hayano Tetsuya Kurihara

6

💡 Sophont Raises $9.22M Seed Round to Advance Multimodal Medical #AI Sacramento-based Sophont, a cutting-edge medical AI #startup, has secured $9.22 million in Seed funding led by Kindred Ventures, with participation from Upfront Ventures, Delphi Ventures, and notable investors including Jeff Dean and Logan Kilpatrick (Google DeepMind), Lukas Biewald (Weights & Biases), and Clément Delangue (Factorial Capital, Hugging Face). Founded by CEO Tanishq Abraham, PhD and CTO Paul Scotti, Sophont is developing multimodal medical foundation models trained on vast, unlabeled clinical data. These AI systems can reason across pathology slides, brain scans, clinical notes, and lab results—driving breakthroughs in: ✅ Symptom triage ✅ Biomarker discovery ✅ Clinical trial patient selection The funding will accelerate development and expand operations as Sophont builds medical AI infrastructure and prepares to release model backbones later this year, enabling med-tech and pharmaceutical R&D teams to fine-tune advanced models for healthcare innovation. #Sophont #MedicalAI #HealthcareInnovation #SeedFunding #AI #DeepLearning #MachineLearning #DigitalHealth #Biotech #MedTech #AIinHealthcare

3

mpathic is becoming THE partner to the AI industry as they work to safeguard users from adverse mental health and safety outcomes As millions of users — including large numbers of young people — increasingly turn to AI chatbots as their first-line “counselors” and confidants, Seattle-based startup mpathic is stepping in to ensure those digital agents don’t provide dangerous advice when it matters most.

33

4 Comments